跳到正文
原文
Endpoints News 生物医药· Max Gelman·· 6 天前AI 评分37

Windward Bio以1.75亿美元在纳斯达克上市,另获赛诺菲5000万美元

Windward Bio hits Nasdaq with $175M IPO, plus another $50M from Sanofi

AI 导读

Windward Bio以1.75亿美元IPO登陆纳斯达克,同时获得赛诺菲(Sanofi)5000万美元投资。该公司是一家专注于开发呼吸系统疾病治疗药物的生物技术公司。

正文

Wind­ward Bio, a biotech de­vel­op­ing drugs for res­pi­ra­to­ry dis­eases, made its pub­lic de­but af­ter putting to­geth­er $175 mil­lion in its IPO.

The com­pa­ny be­gan trad­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news